Good news for patients with
various form of cancer such as brain tumours, head and neck cancer, prostate
cancer and breast cancer following a scientific breakthrough in the UK. According
to report, new cancer treatment centres are ready to welcome patients to their centres.
From 2018, the Rutherford Cancer
Centres will different kind of cancer treatments alongside high energy proton
beam therapy.
Report has it that three centres
are currently under development, in Newport, South Wales, Bomarsund,
Northumberland and Reading, Berkshire.
Proton Beam Therapy is a type of
radiotherapy used in cancer treatment, which distributes severely charged
protons in a précised mode in order to minimise damage to tissue and organs
that are not yet affected.
Though the UK is yet to have such
treatment, countries across the world has successfully delivered Proton Bean
Therapy with remarkable outcome for cancer patients, with particular attention
to reducing the side effects.
The treatment went viral after
six-year-old Aysha King was removed from NHS care by his parents to undergo
proton therapy in the Czech Republic - at the Proton Therapy Centre in Prague.
Since then, dozens of patients
have sought the treatment - with one patient explaining how he ‘fully
recovered’ from prostate cancer following the treatment.
Proton Beam Therapy can be used
for prostate cancer, breast cancer, head and neck cancer, brain tumours.
According to a Proton Therapy
Centre spokesman there is going to be two new centres which are presently being
constructed in the UK - with one housed at Manchester’s Christie Hospital and
one at University College London.
For now, the NHS will still
prefer patients abroad for treatment pending when the centre becomes in
operation in 2018.
The Rutherford Cancer Centre,
South Wales is nearing completion and will offer chemotherapy, radiotherapy and
imaging via the 'latest treatment'.
Positron emission
tomography–computed tomography (PET-CT) will be available in the second half of
this year and proton beam therapy will be available at the centre from early
2018.
However, Treatment at The
Rutherford Cancer Centres will be available to medically-insured private
patients, self-paying patients and patients referred by the NHS.
Professor Gordon McVie, chairman
of Proton Partners International, said: “We’re delighted to announce the
creation of The Rutherford Cancer Centres.
“Proton Partners International is
committed to transforming cancer care in the UK.
“The Rutherford name is
synonymous with a major breakthrough in cancer treatment and therefore we felt
that this was a fitting identity for our treatment centres.
“With cancer on the rise, there
is a growing need for patients to be offered a holistic and sophisticated level
of cancer care.
“Patients at The Rutherford
Cancer Centres will have access to a wide range of cancer services and a
treatment plan will be implemented on an individual basis.”
Mike Moran, chief executive
officer of Proton Partners International, said: “We are working with the
world’s leading technology partners to ensure that our centres are equipped
with the latest cancer technology.
“Our centres will have the
capacity to treat 500 unique patients a year.
We will also network our centres to ensure the data they will provide
can play a significant role in cancer research.
“We are committed to undertaking
a genomics programme which will collate, analyse and distribute data through
our research facility at the Life Sciences Accelerator centre in Liverpool.”
No comments:
Write comments